Ren Fail
And for people on these medications primarily for weight loss, understanding this cardiovascular dimension adds important context to the full picture of what these drugs are doing in the body
Conducted experiments: Lucey, Ashik, Marzook, Wang, Goulding, Elani, Jones Contributed new reagents or analytic tools: Marzook, Oishi, Broichhagen, Hodson, Jockers Performed data analysis: Lucey, Ashik, Goulding, Elani, Jones Wrote or contributed to the writing of the manuscript: all authors Funding acknowledgements The Section of Endocrinology and Investigative Medicine is funded by grants from the Medical Research Council, Biotechnology and Biological Sciences Research Council National Institute of Health Research (NIHR) and is supported by the NIHR Biomedical Research Centre Funding Scheme
Key players: The competitive landscape of GLP-1 peptide CDMOs includes both global and regional firms
Our products are made in cGMP-compliant facilities in the Netherlands, using only the highest quality ingredients
